Firm-Wide

Firm-Wide blog

Burg Simpson Files Two More Product Liability Cases Against DePuy Orthopaedics for Failure of Gentamicin Bone Cement

By Burg Simpson
March 27, 2015
1 min read

As previously reported by Burg Simpson, patients receiving DePuy’s antibiotic-containing bone cement may be at risk of early failure and loosening of their orthopedic implants. Burg Simpson has filed a complaint in the Eastern District of Louisiana against DePuy Orthpaedics, Inc., on behalf of a patient who required a premature revision of her knee implant after the DePuy SmartSet Gentamicin containing bone cement used in her original knee replacement surgery failed to adequately affix the prosthetic device. Burg Simpson also filed a complaint in the District of Oregon against DePuy Orthopaedics, Inc., on behalf of a patient who required a premature revision of her knee implant after the DePuy CMW 1 Gentamicin containing bone cement used in her original knee replacement surgery failed to adequately affix the prosthetic device. FDA adverse event reports indicate that the failure of DePuy’s Gentamicin (antibiotic) bone cement has resulted in the loosening of joint replacement devices. Failure of the bone cement and resulting revision surgery may lead to damage to the bone and surrounding tissue.

Free case evaluation form